1. Home
  2. UDMY vs AVDL Comparison

UDMY vs AVDL Comparison

Compare UDMY & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UDMY
  • AVDL
  • Stock Information
  • Founded
  • UDMY 2009
  • AVDL 2015
  • Country
  • UDMY United States
  • AVDL Ireland
  • Employees
  • UDMY N/A
  • AVDL N/A
  • Industry
  • UDMY Other Consumer Services
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • UDMY Real Estate
  • AVDL Health Care
  • Exchange
  • UDMY Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • UDMY 1.1B
  • AVDL 900.2M
  • IPO Year
  • UDMY 2021
  • AVDL 1996
  • Fundamental
  • Price
  • UDMY $6.52
  • AVDL $9.54
  • Analyst Decision
  • UDMY Buy
  • AVDL Strong Buy
  • Analyst Count
  • UDMY 11
  • AVDL 6
  • Target Price
  • UDMY $10.10
  • AVDL $18.17
  • AVG Volume (30 Days)
  • UDMY 1.2M
  • AVDL 1.6M
  • Earning Date
  • UDMY 07-30-2025
  • AVDL 08-07-2025
  • Dividend Yield
  • UDMY N/A
  • AVDL N/A
  • EPS Growth
  • UDMY N/A
  • AVDL N/A
  • EPS
  • UDMY N/A
  • AVDL N/A
  • Revenue
  • UDMY $790,019,000.00
  • AVDL $194,450,000.00
  • Revenue This Year
  • UDMY $1.87
  • AVDL $56.88
  • Revenue Next Year
  • UDMY $4.15
  • AVDL $29.81
  • P/E Ratio
  • UDMY N/A
  • AVDL N/A
  • Revenue Growth
  • UDMY 5.43
  • AVDL 252.64
  • 52 Week Low
  • UDMY $5.68
  • AVDL $6.38
  • 52 Week High
  • UDMY $10.61
  • AVDL $17.30
  • Technical
  • Relative Strength Index (RSI)
  • UDMY 36.32
  • AVDL 56.42
  • Support Level
  • UDMY $6.78
  • AVDL $8.74
  • Resistance Level
  • UDMY $7.00
  • AVDL $9.56
  • Average True Range (ATR)
  • UDMY 0.22
  • AVDL 0.39
  • MACD
  • UDMY -0.03
  • AVDL 0.04
  • Stochastic Oscillator
  • UDMY 0.00
  • AVDL 81.92

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: